Array
(
[id] => 1285382
[patent_doc_number] => 06635234
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-21
[patent_title] => 'Preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioning'
[patent_app_type] => B1
[patent_app_number] => 09/476569
[patent_app_country] => US
[patent_app_date] => 2000-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6313
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/635/06635234.pdf
[firstpage_image] =>[orig_patent_app_number] => 09476569
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/476569 | Preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioning | Jan 2, 2000 | Issued |
Array
(
[id] => 1483904
[patent_doc_number] => 06365184
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-02
[patent_title] => 'Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID'
[patent_app_type] => B1
[patent_app_number] => 09/471958
[patent_app_country] => US
[patent_app_date] => 1999-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 6
[patent_no_of_words] => 10628
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/365/06365184.pdf
[firstpage_image] =>[orig_patent_app_number] => 09471958
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/471958 | Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID | Dec 22, 1999 | Issued |